Skip to Content

Join the 'Herpes Zoster - Prophylaxis' group to help and get support from people like you.

Herpes Zoster - Prophylaxis News

New Shingles Vaccine, Shingrix, Approved by FDA

Posted 25 Oct 2017 by Drugs.com

A new, more effective shingles vaccine has been approved by the U.S. Food and Drug Administration. The new vaccine from GlaxoSmithKline will be the second shingles vaccine available in the U.S. market. The other is from Merck and was introduced in 2006, the Associated Press reported. Shingles is a painful condition caused by the chickenpox virus. Anyone who's had chickenpox carries the virus that ...

Experimental Shingles Vaccine Looks Quite Effective: Study

Posted 15 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 14, 2016 – An experimental vaccine against shingles may offer lasting protection for most older adults who receive it, a new clinical trial found. Shingles is a painful rash that's triggered by a reactivation of the virus that causes chickenpox. About one-third of Americans develop the disease at some point, according to the U.S. Centers for Disease Control and Prevention (CDC). ...

Asthma May Be Linked to Shingles Risk

Posted 31 Dec 2015 by Drugs.com

THURSDAY, Dec. 31, 2015 – People who suffer from asthma may be more likely to develop the painful skin condition known as shingles, a new study suggests. The finding builds on previous research that suggested a link between childhood asthma and shingles risk. "Asthma represents one of the five most burdensome chronic diseases in the U.S., affecting up to 17 percent of the population," said study ...

Start of School Year Calls for Vaccine Check

Posted 21 Aug 2015 by Drugs.com

FRIDAY, Aug. 21, 2015 – With the start of a new school year, many parents are searching for vaccination records and hoping they're current, but what does "up-to-date" look like these days? That depends on whether it's what the school requires or what pediatric experts recommend. "Not all vaccines that we recommend on the schedule are required by schools," said Wendy Sue Swanson, a pediatrician ...

Infectious-Disease Expert Debunks Common Vaccine Myths

Posted 12 May 2015 by Drugs.com

TUESDAY, May 12, 2015 – A small minority of people still distrust the safety of routine childhood vaccinations, but one expert says the myths that swirl around vaccines are easily dismissed. "Both parents and doctors have the same goal, to keep a child healthy, and the best way to keep a child safe is through vaccination," said Dr. Nadia Qureshi, a pediatric infectious disease specialist at ...

Shingles Vaccine Still Effective After Chemotherapy

Posted 8 Aug 2014 by Drugs.com

FRIDAY, Aug. 8, 2014 – The shingles vaccine remains effective in older people after they've had chemotherapy, a new study finds. "The zoster vaccine (Zostavax) has been shown to be safe and effective in elderly adults with healthy immune systems but until now, there has been a lack of data on whether the vaccine remains safe and effective for individuals who might have compromised immune systems ...

Few U.S. Seniors Take Advantage of Shingles Vaccine

Posted 9 Apr 2013 by Drugs.com

TUESDAY, April 9 – The shingles vaccine is effective but few American seniors get it, according to a new study. Shingles is a painful skin and nerve infection that occurs when the chickenpox virus is reactivated in older adults who had chickenpox as children. The vaccine helps prevent reactivation of the virus. Researchers led by Sinead Langan from the London School of Hygiene and Tropical ...

Shingles Vaccine Safe, Underutilized, Study Says

Posted 23 Apr 2012 by Drugs.com

MONDAY, April 23 – The shingles vaccine is generally safe and well tolerated by patients, according to a new study. Shingles, which affects more than 1 million people each year in the United States, is a painful contagious rash caused by the dormant chickenpox virus, which can reactivate and replicate, damaging the nervous system. Elderly people are especially at risk because immunity against ...

Fear Proves Prime Motivator for Vaccinations

Posted 16 Sep 2011 by Drugs.com

FRIDAY, Sept. 16 – Sometimes a little fear might be a good thing. To run an effective public vaccination program, you've got to make sure that adequate amounts of the vaccine are available and there are enough staff members to administer it, said Dr. Adewale Troutman, director of the public health practice program at the University of South Florida, who, until recently, headed the Department of ...

U.S. Shingles Vaccine Approval Expanded

Posted 26 Mar 2011 by Drugs.com

THURSDAY, March 24 – The Zostavax shingles vaccine is now approved by the U.S. Food and Drug Administration for people aged 50 and older. FDA-sanctioned use of the vaccine, first approved in 2006, had been limited to people 60 and older. The expanded approval includes the about 200,000 people aged 50 to 59 who contract shingles each year, the agency said in a news release. Shingles is caused by ...

Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease

Posted 12 Jan 2011 by Drugs.com

Kaiser Permanente Research Strengthens National Recommendations PASADENA, Calif., Jan. 11, 2011 /PRNewswire/ – Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association. This retrospective study observed the ...

Shingles Vaccine Looks Like a Safe Bet for Seniors: Study

Posted 11 Jan 2011 by Drugs.com

TUESDAY, Jan. 11 – Jane Adrian, 61, a landscape architect in Glendale, Calif., saw her parents and two co-workers suffer from the painful, blistering condition known as shingles, so when the vaccine became available, she got it. Even though the vaccine is only about 55 percent effective, "it's better than nothing," she said. "Now I feel relieved." A study of a cross-section of adults enrolled ...

Ask a Question

Further Information

Related Condition Support Groups

Vaccination and Prophlaxis

Related Drug Support Groups

Zostavax, Shingrix, zoster vaccine live, zoster vaccine (recombinant)